Investors

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

2020 – 2024

2024

2023

2022

2021

Annual Report 2021 (English version)

2020

Calendar and upcoming reports

August 22, 2024
Interim Report Q2 2024 (7:00am CEST)

November 8, 2024
Interim Report Q3 2024 (7:00am CET)

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com